Previous 10 | Next 10 |
Brickell Biotech, Inc. (BBI) Q1 2021 Earnings Conference Call May 13, 2021 16:30 ET Company Participants Garth Russell - Investor Relations, LifeSci Advisors Robert Brown - Chief Executive Officer Deepak Chadha - Chief R&D Officer Bert Marchio - Chief Financial Officer Conference Call Par...
Brickell Biotech (BBI): Q1 GAAP EPS of -$0.15 misses by $0.03.Strengthened the Company’s balance sheet to $34.8 million in cash and cash equivalents at the end of the first quarter of 2021, which includes aggregate net proceeds of $10.6 million from warrant exercises and the ...
Completed enrollment in Phase 3 pivotal Cardigan I study and exceeded 70% enrollment in Phase 3 pivotal Cardigan II study - - - Topline results for Phase 3 pivotal Cardigan I and Cardigan II studies expected in Q4 2021 - - - Presented results from Phase 3 open-labe...
Brickell Biotech is conducting two important phase III studies of its investigational drug to treat excessive sweating. These studies, CARDIGAN I and II, should produce topline results later in 2021. Eli Lilly already has a medication approved in this space, limiting the drug's re...
BOULDER, Colo., April 29, 2021 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, today an...
Brickell Biotech (BBI) announces the completion of patient enrollment in the Phase 3 pivotal Cardigan I study evaluating sofpironium bromide gel, 15% in patients with primary axillary (underarm) hyperhidrosis.Shares up more than 2% premarket.Hyperhidrosis is a debilitating cond...
Phase 3 Pivotal Cardigan II study exceeds 50% enrollment - - - Topline results for Phase 3 Pivotal Cardigan I and Cardigan II clinical studies expected in Q4 2021 BOULDER, Colo., April 27, 2021 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell” or the &...
Should These Be On Your List Of Penny Stocks To Buy? Trading penny stocks is simple in theory. You find cheap shares, hit the buy button on your broker platform, then sell when your profit target is reached. However, when it comes to finding the top penny stocks to buy, a lot more e...
Are These Biotech Penny Stocks on Your Watchlist? As April comes to an end, investors are still searching for the best penny stocks to buy . Whether due to the pandemic or not, 2021 has been the year for biotech penny stocks . While Covid had a negative impact on most industries...
Daily treatment with sofpironium bromide gel was generally well-tolerated over 48 weeks of treatment Efficacy assessments showed a clinically meaningful and sustained improvement in sweat severity through the 48 weeks of treatment Data presented today in a late-breaking ...
News, Short Squeeze, Breakout and More Instantly...
Brickell Biotech Inc. Company Name:
BBI Stock Symbol:
NYSE Market:
New name, logo, website, and branding reflect the Company’s strategic shift toward developing potentially groundbreaking autoimmune and inflammatory disease therapies Company to begin trading under new ticker symbol “FRTX” on September 8, 2022 Compan...
Phase 1 study of BBI-02 progressing well and expect to initiate MAD part of the study next month On track to report SAD and MAD topline results from BBI-02 Phase 1 study by early 2023 Development of BBI-10 and next-generation kinase inhibitors advancing through early precl...
BOULDER, Colo., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription therapeutics for the treatment of autoi...